Tech Company Financing Transactions
Harmony Biosciences Funding Round
Fidelity Management & Research Company, HBM Healthcare Investments and Nan Fung Life Sciences joined a $270 million venture round for Harmony Biosciences. The round was announced on 10/10/2017.
Transaction Overview
Company Name
Announced On
10/10/2017
Transaction Type
Venture Equity
Amount
$270,000,000
Round
Undisclosed
Investors
Proceeds Purpose
This funding will enable Harmony to fulfill its mission of providing novel treatment options to patients with orphan and rare conditions, with a focus on CNS disorders.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
630 W Germantown Pike 220
Plymouth Meeting, PA 19462
USA
Plymouth Meeting, PA 19462
USA
Phone
Undisclosed
Website
Email Address
Overview
Harmony Biosciences (Nasdaq: HRMY) is an innovative biopharmaceutical company dedicated to identifying, developing, and commercializing novel treatment options for patients with rare diseases. With an emphasis on Central Nervous System (CNS) disorders, our goal is to push the boundaries of what science can do to improve the lives of patients.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Jacobs
Chief Financial Officer
Susan Drexler
Chief Medical Officer
Jeffrey Dayno
VP - Bus. Development
Andrew Serafin
VP - General Counsel
Stephanie Wisdo
Browse more venture capital transactions:
Prev: 10/9/2017: Zenflow venture capital transaction
Next: 10/10/2017: The Honest Company venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. All VC database entries reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs